Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 9
Submit an article Journal homepage
482
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluations

Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis

Rosita SaracenoUniversity of Rome Tor Vergata, U.O.C. of Dermatology, Viale Oxford 81, 00133, Rome, Italy+39 06 26902743; +39 06 20902742; [email protected]
, MD,
Mauro BavettaUniversity of Rome Tor Vergata, U.O.C. of Dermatology, Viale Oxford 81, 00133, Rome, Italy+39 06 26902743; +39 06 20902742; [email protected]
, MD,
Arianna ZangrilliUniversity of Rome Tor Vergata, U.O.C. of Dermatology, Viale Oxford 81, 00133, Rome, Italy+39 06 26902743; +39 06 20902742; [email protected]
, MD,
Andrea ChiricozziUniversity of Rome Tor Vergata, U.O.C. of Dermatology, Viale Oxford 81, 00133, Rome, Italy+39 06 26902743; +39 06 20902742; [email protected]
, MD,
Concetta PotenzaUniversity of Rome “La Sapienza” U.O.C. of Dermatology, (Polo Pontino), Rome, Italy
, MD,
Sergio ChimentiUniversity of Rome Tor Vergata, U.O.C. of Dermatology, Viale Oxford 81, 00133, Rome, Italy+39 06 26902743; +39 06 20902742; [email protected]
, MD &
Maria Sole ChimentiUniversity of Rome Tor Vergata, U.O.C. of Rheumatology, Rome, Italy
, MD show all
Pages 1325-1334 | Published online: 10 Aug 2013

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Akimichi Morita, Ryuhei Okuyama, Norito Katoh, Chiharu Tateishi, Koji Masuda, Toshifumi Komori, Eisaku Ogawa, Takamitsu Makino, Emi Nishida, Shohei Nishimoto, Kenzo Muramoto, Daisuke Tsuruta & Hironobu Ihn. (2020) Efficacy and safety of adalimumab in Japanese patients with psoriatic arthritis and inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs): A prospective, observational study. Modern Rheumatology 30:1, pages 155-165.
Read now
Maria Sole Chimenti, Talia Gramiccia, Rosita Saraceno, Luca Bianchi, Virginia Garofalo, Oreste Buonomo, Roberto Perricone, Sergio Chimenti & Andrea Chiricozzi. (2015) Apremilast for the treatment of psoriasis. Expert Opinion on Pharmacotherapy 16:13, pages 2083-2094.
Read now

Articles from other publishers (6)

N. N. Potekaev, O. V. Zhukova & S. I. Artemyeva. (2020) Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies. Meditsinskiy sovet = Medical Council:12, pages 28-34.
Crossref
Miao Chen & Sheng-Ming Dai. (2020) A novel treatment for psoriatic arthritis: Janus kinase inhibitors. Chinese Medical Journal 133:8, pages 959-967.
Crossref
A. Chiricozzi, A. Zangrilli, M. Bavetta, L. Bianchi, S. Chimenti & R. Saraceno. (2017) Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. Journal of the European Academy of Dermatology and Venereology 31:2, pages 304-311.
Crossref
A. Chiricozzi, M.V. Cannizzaro, G.A. Salandri, B. Marinari, R. Pitocco, A. Dattola, F. Regine, R. Saraceno, L. Bianchi, S. Chimenti & A. Costanzo. (2016) Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy. Journal of the European Academy of Dermatology and Venereology 30:11, pages e128-e129.
Crossref
Li Luan, Shixin Han, Hua Wang & Xiaoming Liu. (2015) Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis. International Immunopharmacology 29:2, pages 278-284.
Crossref
Lucia Novelli, Maria Sole Chimenti, Andrea Chiricozzi & Roberto Perricone. (2014) The new era for the treatment of psoriasis and psoriatic arthritis: Perspectives and validated strategies. Autoimmunity Reviews 13:1, pages 64-69.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.